Crossmark

Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s40814-023-01373-4

Published Online: 2023-08-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ismail, Heba M. http://orcid.org/0000-0003-0102-0030
Spall, Maria

Evans-Molina, Carmella

DiMeglio, Linda A.
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (KL2TR002530, UL1TR002529)
License Information

Text and Data Mining valid from 2023-08-25

Version of Record valid from 2023-08-25
More Information

Article History

Received: 20 September 2022

Accepted: 3 August 2023

First Online: 25 August 2023

Declarations

:

: The study was approved by the Institutional Review Board at Indiana University.Verbal and written information regarding informed consent will be presented to the caregivers and/or patients. Any modifications to the protocol that may affect the conduct of the study will be presented to the committee. The full protocol will be available freely due to open access publication. The findings of this trial will be submitted to a peer-reviewed journal. Abstracts will be submitted to relevant national and international conferences. The standards from the guidelines of the Consolidated Standards of Reporting Trials will be followed for this RCT. All investigators will have access to the final trial dataset.

: The authors all agree to the publication of this material.

: All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below